|
RAD54L2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.191190E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.137030E-03 |
| Normal-vs-Stage2 |
1.374420E-02 |
| Normal-vs-Stage3 |
1.77348999998994E-05 |
| Normal-vs-Stage4 |
2.157300E-04 |
| Stage1-vs-Stage2 |
9.424200E-01 |
| Stage1-vs-Stage3 |
1.543440E-01 |
| Stage1-vs-Stage4 |
3.153400E-01 |
| Stage2-vs-Stage3 |
3.156600E-01 |
| Stage2-vs-Stage4 |
3.879800E-01 |
| Stage3-vs-Stage4 |
9.735000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.015200E-04 |
| Normal-vs-AfricanAmerican |
1.345150E-01 |
| Normal-vs-Asian |
4.355900E-04 |
| Caucasian-vs-AfricanAmerican |
3.329800E-01 |
| Caucasian-vs-Asian |
3.711000E-01 |
| AfricanAmerican-vs-Asian |
1.452630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.8037999999796E-06 |
| Normal-vs-Female |
7.233800E-04 |
| Male-vs-Female |
1.036000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.877400E-03 |
| Normal-vs-Age(41-60Yrs) |
8.09220000000943E-05 |
| Normal-vs-Age(61-80Yrs) |
2.014900E-04 |
| Normal-vs-Age(81-100Yrs) |
2.168200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.797030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.003200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.028000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.101600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.684000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.178000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.639700E-02 |
| Classical-VS-Follicular |
5.164300E-02 |
| Classical-VS-Other |
4.330300E-02 |
| Classical-VS-Normal |
2.963900E-03 |
| Tall-VS-Follicular |
5.048600E-01 |
| Tall-VS-Other |
2.251000E-01 |
| Tall-VS-Normal |
7.94400000000417E-05 |
| Follicular-VS-Other |
1.815970E-01 |
| Follicular-VS-Normal |
1.152770E-04 |
| Other-VS-Normal |
1.035880E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.89380000000484E-05 |
| Normal-vs-N1 |
2.970400E-04 |
| N0-vs-N1 |
5.380000E-01 |
|
|
